Cargando…
How to maintain the maximal level of blinding in randomisation for a placebo-controlled drug trial
We illustrate the approach of randomising treatments and compare it with the traditional approach of randomising patients, using a case study drawn from the authors’ experience in clinical trials. The setting is a double-blind parallel two-arm randomised controlled trial (RCT), but the method in thi...
Autores principales: | Clifton, Lei, Clifton, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462539/ https://www.ncbi.nlm.nih.gov/pubmed/31011659 http://dx.doi.org/10.1016/j.conctc.2019.100356 |
Ejemplares similares
-
Placebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo
por: Keränen, Tapani, et al.
Publicado: (2015) -
Simulating therapeutic drug monitoring results for dose individualisation to maintain investigator blinding in a randomised controlled trial
por: Lesosky, Maia, et al.
Publicado: (2017) -
Randomised, Double Blind, Placebo-Controlled Trial of Echinacea Supplementation in Air Travellers
por: Tiralongo, E., et al.
Publicado: (2012) -
Extensively hydrolysed casein formula supplemented with Lactobacillus rhamnosus GG maintains hypoallergenic status: randomised double-blind, placebo-controlled crossover trial
por: Muraro, Antonella, et al.
Publicado: (2012) -
Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial
por: Mullen, Michael, et al.
Publicado: (2019)